| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/06/1998 | WO1998033524A1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| 08/06/1998 | WO1998033509A2 Useful properties of human lactoferrin and variants thereof |
| 08/06/1998 | WO1998033508A1 Calcareous material |
| 08/06/1998 | WO1998033498A1 Drugs for memory enhancement |
| 08/06/1998 | WO1998033480A1 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 08/06/1998 | WO1998024763A3 Immunotherapeutic imides/amides as pde iv and tnf inhibitors |
| 08/06/1998 | WO1998021332A3 Secreted proteins and polynucleotides encoding them |
| 08/06/1998 | WO1998021220A3 Saccharide derivatives |
| 08/06/1998 | WO1998018440A3 Use of inhibitors of the activity of retinoic acid for treating sensitive skin |
| 08/06/1998 | CA2280096A1 Nanomolar, non-peptide inhibitors of cathepsin d |
| 08/06/1998 | CA2279947A1 Drugs for memory enhancement |
| 08/06/1998 | CA2279594A1 Calcareous material |
| 08/06/1998 | CA2279459A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use |
| 08/06/1998 | CA2279178A1 Endothelin antagonists: n-[[2'-[ [(4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide and salts thereof |
| 08/06/1998 | CA2278848A1 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use |
| 08/06/1998 | CA2277965A1 Dihydropyrimidone derivatives as npy antagonists |
| 08/06/1998 | CA2271157A1 Pyrido[2,3-d]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation |
| 08/05/1998 | EP0856514A1 8-substituted-1,3,8-triazaspiro[4.5]decan-4-on derivatives |
| 08/05/1998 | EP0856513A2 Thalidomide analogues from the piperidine-2,6-dione class |
| 08/05/1998 | EP0856050A1 Transforming growth factor alpha hi |
| 08/05/1998 | EP0856007A1 Cyclopeptide derivatives |
| 08/05/1998 | EP0855999A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 08/05/1998 | EP0766687B1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 08/05/1998 | EP0752990B1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis |
| 08/05/1998 | EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/05/1998 | EP0674505B1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails |
| 08/05/1998 | EP0642518B1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism |
| 08/05/1998 | EP0553263B1 1'-aminospiro-[isoquinoline-4(1h),3'-pyrrolidine]- 1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo |
| 08/05/1998 | CN1189834A Condesned thiazole derivatives, having 5-HT receptor affinity |
| 08/05/1998 | CN1189832A Diazepino-indoles as phosphodiesterase IV inhibitors |
| 08/05/1998 | CN1189829A Piperazino derivatives as neurokinin antagonists |
| 08/05/1998 | CN1189823A Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 08/05/1998 | CN1189821A Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 08/05/1998 | CN1189779A Cascade polymer complexes, its preparation process and medicine containing cascade polymer |
| 08/05/1998 | CN1189491A Isoxazole and crotonamide derivatives and their use as pharmaceuticals and disgnositics |
| 08/05/1998 | CN1189490A Process for preparing 1-biphenylmethylimidazole derivatives |
| 08/05/1998 | CN1039416C Process for preparing novel pyrido (3,2-B) (1.5) benzothiazepines |
| 08/04/1998 | US5789547 Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding |
| 08/04/1998 | US5789543 Vertebrate embryonic pattern-inducing proteins and uses related thereto |
| 08/04/1998 | US5789447 Nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
| 08/04/1998 | US5789434 Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
| 08/04/1998 | US5789432 Aromatase-inhibiting composition containing azole derivative |
| 08/04/1998 | US5789426 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
| 08/04/1998 | US5789416 Cardiovascular and nervous system disorders |
| 08/04/1998 | US5789414 Protect dna from damage |
| 08/04/1998 | US5789404 Central nervous system disorders and antiserotonin agents |
| 08/04/1998 | US5789395 Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
| 08/04/1998 | US5789391 Method of treating sinusitis with uridine triphosphates and related compounds |
| 08/04/1998 | US5789380 Agents for inhibiting accumulation of visceral fat |
| 08/04/1998 | US5789000 Mixture with 2,2'-dithio-bis-ethane sulfonate |
| 08/04/1998 | US5788984 Gestodene-containing agent for transdermal administration |
| 08/04/1998 | US5788970 Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon |
| 08/04/1998 | US5788965 Used to treat coagulation-related disorders |
| 08/04/1998 | US5788958 Using nitrous oxide synthase inhibitor |
| 08/04/1998 | US5788953 Comprising water having lowered deuterium content |
| 08/04/1998 | CA2149242C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
| 08/04/1998 | CA2102210C Combined calcium and vitamin d supplements |
| 08/04/1998 | CA2101275C Methods for the treatment of osteoporosis |
| 08/04/1998 | CA2071093C Ethanolamine benzoate derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 08/04/1998 | CA1339982C Antioxidant composition and production method thereof |
| 08/01/1998 | CA2228385A1 Compounds analogous to thalidomide from the class comprising piperdine-2,6-diones |
| 07/30/1998 | WO1998032863A2 Mammalian thioredoxin |
| 07/30/1998 | WO1998032853A2 Secreted proteins and polynucleotides encoding them |
| 07/30/1998 | WO1998032851A1 Two human homologues of galectin-5 |
| 07/30/1998 | WO1998032766A1 SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS |
| 07/30/1998 | WO1998032753A1 THIAZOLE BENZENESULFONAMIDES AS β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 07/30/1998 | WO1998032751A1 Process for the production of semi synthetic statins via novel intermediates |
| 07/30/1998 | WO1998032748A1 Sulfamide-metalloprotease inhibitors |
| 07/30/1998 | WO1998032740A1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same |
| 07/30/1998 | WO1998032734A1 SUBSTITUTED β-THIOCARBOXYLIC ACIDS |
| 07/30/1998 | WO1998032732A1 5-aroylnaphthalene derivatives |
| 07/30/1998 | WO1998032463A2 Lyophilizate of lipid complex of water insoluble porphyrins |
| 07/30/1998 | WO1998032457A2 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 07/30/1998 | WO1998032455A1 The extract of pine needle and the use thereof |
| 07/30/1998 | WO1998032454A1 Centipeda plant extract |
| 07/30/1998 | WO1998032453A1 Facilitation of wound healing with cm101/gbs toxin |
| 07/30/1998 | WO1998032450A1 Bone regeneration in osteoporosis using human bone marrow mesenchymal cells |
| 07/30/1998 | WO1998032444A1 USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION |
| 07/30/1998 | WO1998032441A1 Use of central cannabinoid receptor antagonists for regulating appetence |
| 07/30/1998 | WO1998032440A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator |
| 07/30/1998 | WO1998032439A1 Il-8 receptor antagonists |
| 07/30/1998 | WO1998032438A1 Il-8 receptor antagonists |
| 07/30/1998 | WO1998027108A3 New amide compounds and their use as nitric oxide synthase inhibitors |
| 07/30/1998 | WO1998024478A3 Tumour therapy |
| 07/30/1998 | WO1998021237A3 Peptide compounds useful for modulating FGF receptor activity |
| 07/30/1998 | WO1998010787A3 Pharmaceutical compositions for the treatment of immune disorders |
| 07/30/1998 | DE19803003A1 5-Aroylnaphthalinderivate 5-Aroylnaphthalinderivate |
| 07/30/1998 | DE19802350A1 Sulfamid-Metalloprotease-Inhibitoren Sulfamide metalloprotease inhibitors |
| 07/30/1998 | CA2279261A1 The extract of pine needle and the use thereof |
| 07/30/1998 | CA2279241A1 Mammalian thioredoxin |
| 07/30/1998 | CA2278779A1 Substituted amino bicyclic-.beta.-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 07/30/1998 | CA2278770A1 Secreted proteins and polynucleotides encoding them |
| 07/30/1998 | CA2278739A1 Thiazole benzenesulfonamides as .beta.3 agonists for the treatment of diabetes and obesity |
| 07/30/1998 | CA2278737A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 07/30/1998 | CA2278661A1 Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour reguler l'appetance |
| 07/30/1998 | CA2278603A1 Process for the production of semi synthetic statins via novel intermediates |
| 07/30/1998 | CA2278539A1 Bone regeneration in osteoporosis using human bone marrow mesenchymal cells |
| 07/30/1998 | CA2278504A1 Il-8 receptor antagonists |
| 07/30/1998 | CA2278463A1 Two human homologues of galectin-5 |
| 07/30/1998 | CA2278427A1 Il-8 receptor antagonists |